The additional feature is their low AChE/BChE selectivity, which indicate their potential to be used in early to late stages of AD, considering that ACh is mainly hydrolysed by AChE in the early stage and by BChE in the late. The gene discussed is BCHE; the disease is Alzheimer disease.